Efavirenz Use in HIV Infected Patients and Neurocognitive Impairment: Study Findings
This study explores the relationship between the use of efavirenz and neurocognitive impairment in HIV infected patients. The study found that there was no increased risk of neurocognitive impairment associated with the use of efavirenz.
- Uploaded on | 1 Views
-
jocelyn
About Efavirenz Use in HIV Infected Patients and Neurocognitive Impairment: Study Findings
PowerPoint presentation about 'Efavirenz Use in HIV Infected Patients and Neurocognitive Impairment: Study Findings'. This presentation describes the topic on This study explores the relationship between the use of efavirenz and neurocognitive impairment in HIV infected patients. The study found that there was no increased risk of neurocognitive impairment associated with the use of efavirenz.. The key topics included in this slideshow are efavirenz, HIV, neurocognitive impairment, antiretroviral therapy, patient safety,. Download this presentation absolutely free.
